TSO3 Inc – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

TSO3 Inc (TSO3) design, develops, manufactures, markets and licenses sterilization processes for heat-sensitive medical devices. The company’s area of focus is sterile processing, which provides a replacement solution to other low temperature sterilization processes used in hospitals. The company’s flagship product is Sterizone VP4 Sterilizer, a dual sterilant, low-temperature sterilization system, which utilizes vaporized hydrogen peroxide and ozone. The company’s product is based on its patented Sterizone sterilization platform. The company also offers services such as maintenance of sterilization equipment and compatibility testing of medical devices. The product finds use in hospitals and clinical settings with high patient turnover. TSO3 is headquartered in Quebec, Canada.

TSO3 Inc Key Recent Developments

Sep 26,2019: TSO3 announces receipt of final Court approval for plan of arrangement with Stryker
Aug 12,2019: TSO3 reports second quarter 2019 results
May 06,2019: TSO3 reports first quarter 2019 results
Apr 02,2019: TSO3 announces changes to the Board of Directors
Mar 27,2019: TSO3 reports fourth quarter and full year 2018 results

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.